Join Dr. Michael Abramoff, MD, PhD, Founder and Executive Chairman of Digital Diagnostics as he takes part of the NIH Bridge 2 AI where he will talk about FDA regulatory pathways for AI clinical tools, with a particular focus on the equity/data drift/bias issues.
Ethical, Legal, and Social Implications (ELSI) of Artificial Intelligence